IPO registrations (S-1, F-1) · Registrants
Innoveren Scientific, Inc.
- SEC CIK
- 1591165 · filings on EDGAR ↗
- Name on the registration
- H-CYTE, INC.
- Former names
- H-CYTE, INC. (2019–2023); Medovex Corp. (2014–2019); SpineZ (2013–2014)
- Registration
- Form S-1, first filed 2014-09-08, last 2022-02-10; 4 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2014-12-19; declared effective 2014-12-18
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- NV
- Business address
- 151 W4TH ST, STE 223, Cincinnati, OH 45202
- EIN
- 46-3312262
- EDGAR entity type
- operating
- Insiders and CEO pay
- Innoveren Scientific, Inc. on the corporate pages
Offering terms
- Final price
- $5.75 per share (424B4 filed 2014-12-19, an initial public offering)
- Shares sold
- 1,391,305
- Gross proceeds
- $8,000,004 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MDVX
- Lead underwriters
- Laidlaw & Company (1,391,305 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: H-CYTE, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form D issuer: H-CYTE, INC. EXACT (CIK (EXACT))
- SEC filer: H-CYTE, INC. EXACT (CIK (EXACT))
Filings 21
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-09-08 | S-1 | S-1 (registration) | Medovex Corp. | 0001415889-14-002725 ↗ |
| 2014-10-07 | S-1/A | S-1/A (amendment) | Medovex Corp. | 0001415889-14-003015 ↗ |
| 2014-11-12 | S-1/A | S-1/A (amendment) | Medovex Corp. | 0001415889-14-003429 ↗ |
| 2014-11-26 | S-1/A | S-1/A (amendment) | Medovex Corp. | 0001415889-14-003705 ↗ |
| 2014-12-02 | S-1/A | S-1/A (amendment) | Medovex Corp. | 0001415889-14-003773 ↗ |
| 2014-12-09 | S-1/A | S-1/A (amendment) | Medovex Corp. | 0001415889-14-003829 ↗ |
| 2014-12-18 | EFFECT | EFFECT (declared effective) | Medovex Corp. | 9999999995-14-003734 ↗ |
| 2014-12-19 | 424B4 | 424B4 (final prospectus) | Medovex Corp. | 0001415889-14-003944 ↗ |
| 2016-06-17 | S-1 | S-1 (registration) | Medovex Corp. | 0001415889-16-006247 ↗ |
| 2016-07-01 | EFFECT | EFFECT (declared effective) | Medovex Corp. | 9999999995-16-005070 ↗ |
| 2016-07-05 | 424B1 | 424B1 (final prospectus) | Medovex Corp. | 0001415889-16-006361 ↗ |
| 2016-07-05 | 424B4 | 424B4 (final prospectus) | Medovex Corp. | 0001415889-16-006362 ↗ |
| 2017-05-05 | EFFECT | EFFECT (declared effective) | Medovex Corp. | 9999999995-17-001200 ↗ |
| 2017-05-05 | EFFECT | EFFECT (declared effective) | Medovex Corp. | 9999999995-17-001202 ↗ |
| 2020-07-02 | S-1 | S-1 (registration) | H-CYTE, INC. | 0001493152-20-012424 ↗ |
| 2020-07-31 | S-1/A | S-1/A (amendment) | H-CYTE, INC. | 0001493152-20-014263 ↗ |
| 2020-08-04 | EFFECT | EFFECT (declared effective) | H-CYTE, INC. | 9999999995-20-002018 ↗ |
| 2022-02-07 | S-1 | S-1 (registration) | H-CYTE, INC. | 0001493152-22-003330 ↗ |
| 2022-02-10 | S-1/A | S-1/A (amendment) | H-CYTE, INC. | 0001493152-22-003697 ↗ |
| 2022-02-14 | EFFECT | EFFECT (declared effective) | H-CYTE, INC. | 9999999995-22-000460 ↗ |
| 2022-02-16 | 424B4 | 424B4 (final prospectus) | H-CYTE, INC. | 0001493152-22-004781 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-12-09 | S-1/A | registration statement | $5.75 | 1,391,305 | $8,000,004 | Nasdaq MDVX | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2014-12-19 | 424B4 | final prospectus | $5.75 | 1,391,305 | $8,000,004 | Nasdaq MDVX | 1 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Thomas John C | Director | 5 | 2015–2017 | ||
| Betz Randal R | Director | 6 | 2015–2018 | ||
| Kullmann Patrick C | Officer | COO, PRESIDENT; President and COO; PRESIDENT AND COO | 6 | 2015–2017 | |
| Haufe Scott | Director | 9 | 2015–2017 | ||
| Farrahar Charles Duane | Officer | Chief Financial Officer | 1 | 2015 | |
| Moon Dennis Glenn | Officer | Executive Vice President; EXECUTIVE VICE PRESIDENT | 4 | 2015–2017 | |
| PAPASAN LARRY W | Director; Director,Officer | Chief Financial Officer | 3 | 2015–2017 | |
| Gorlin Jarrett S | Director,Officer; Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 8 | 2015–2017 | |
| ANDREWS JAMES R M D | Director | 3 | 2015–2017 | ||
| GORLIN STEVE | Director; Other | 13 | 2015–2017 | ||
| Hennies Clyde A. | Director | 3 | 2015–2017 | ||
| Hills Thomas Edward | Director | 2 | 2015 | ||
| Wright Jeffery Scott | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 3 | 2015–2017 | |
| Sablowski Manfred | Officer | Senior Vice President; SENIOR VICE PRESIDENT; VP OF SALES AND MARKETING | 5 | 2015–2017 | |
| Lawson James Ronald JR | Director | 4 | 2016–2017 | ||
| Mogford Jon | Director | 5 | 2016–2017 | ||
| Crowne Jesse | Director | 4 | 2017–2018 | ||
| Horne William E | Director; Director,Officer | Chief Executive Officer | 7 | 2019–2021 | |
| Yurkowsky Michael | Director; TenPercentOwner | 5 | 2019–2021 | ||
| FARRIOR J REX III | TenPercentOwner | 4 | 2020–2024 | ||
| FWHC HOLDINGS, LLC | TenPercentOwner | 5 | 2020–2024 | ||
| HOA CAPITAL LLC | TenPercentOwner | 4 | 2020–2024 | ||
| Greif Robert Smith | Officer | Chief Executive Officer; President and C.E.O. | 2 | 2020–2021 | |
| FWHC BRIDGE FRIENDS, LLC | TenPercentOwner | 3 | 2021–2024 | ||
| Monteleone Raymond | Director | 2 | 2021 | ||
| FWHC BRIDGE, LLC | TenPercentOwner | 3 | 2021–2024 | ||
| WAGNER TODD R | TenPercentOwner | 4 | 2021–2024 | ||
| Daniel Jeremy | Officer | Chief Financial Officer | 3 | 2021 | |
| CFRS INVESTMENTS, LLC | TenPercentOwner | 2 | 2022 | ||
| Lynch Frederick J | TenPercentOwner | 2 | 2022 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-05-05 | H-CYTE, INC. | Other Health Care | $2,880,195 | $2,880,195 | 32 | 1 |
| 2019-11-27 | H-CYTE, INC. | Other Health Care | $9,750,000 | $6,000,000 | 1 | 1 |
| 2018-05-16 | Medovex Corp. | Biotechnology | $1,000,000 | $340,000 | 7 | 1 |
| 2016-05-03 | Medovex Corp. | Other Health Care | $2,000,000 | $1,398,033 | 32 | 1 |
| 2015-04-07 | Medovex Corp. | Other Health Care | Indefinite | $0 | 92 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | H-CYTE, INC. | FL | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | H-CYTE, INC. | FL | Form D private offerings | CIK (EXACT) |
| SEC filer | Innoveren Scientific, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, OH first:
- AtriCure, Inc. OH
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
- EVOME MEDICAL TECHNOLOGIES INC. A1
- Breathe BioMedical Inc. A3
- LEGACY VENTURES INTERNATIONAL INC. A6
- TITAN MEDICAL INC A6
- LIFEPOINT INC A6
In other datasets, the same topic (Technology) in OH:
- Form D issuer: 10XTS INC (Form D private offerings)
- Lobbying client: ADS ALLIANCE DATA SYSTEMS (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology